4//SEC Filing
Novak Alfred J 4
Accession 0001213900-24-053005
CIK 0001841330other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:25 PM ET
Size
7.0 KB
Accession
0001213900-24-053005
Insider Transaction Report
Form 4
Novak Alfred J
Director
Transactions
- Award
Common Stock
2024-06-13$5.62/sh+2,750$15,455→ 3,500 total - Award
Common Stock
2024-06-12$5.61/sh+750$4,208→ 750 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.60 to $5.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.55 to $5.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
Related Parties
1- filerCIK 0001388862
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 5:25 PM ET
- Size
- 7.0 KB